PIQUR Therapeutics Companies
PIQUR Therapeutics is a Swiss pharmaceutical company that develops innovative anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition, with a focus on oncology and dermatology. The company has a secured patent scope protecting many chemical compounds, and their lead compound bimiralisib targets the dual inhibition of the PI3K/mTOR pathway. PIQUR Therapeutics was founded in 2011 and is based in Basel, Switzerland.
Industry:
Advanced BioTech R&D